Many pathological liver conditions, such as liver fibrosis, chronic hepatitis C, autoimmune hepatitis, and non-alcoholic fatty liver disease, show a strong correlation with TGF-β-related signaling. The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatotic liver disease.